PrimoGAIA
PrimoGaia opens up a new pathway in Magnetic Resonance Imaging (MRI) by initiating the concept of in vivo “enzymatic imaging” for a better understanding of human physiology, early detection and prognosis of diseases, monitoring of therapeutic treatment.
The project
| 7 partners 4 countries H2020 FET Open |
Start: 01-12-2019 end: 31-05-2023 |
News
#magnetic resonance imaging (MRI), #dynamic nuclear polarization (DNP), #overhauser MRI (OMRI), #enzyme activity, #ultra-low field, #contrast agents, #inflammatory diseases, #enzymatic mapping, #cost efficient sytems, #medical engineering
1st Workshop on Emerging Trends in Molecular Imaging 2023
We are pleased to announce the first workshop on Emerging Trends in Molecular Imaging, jointly organised by the Molecular Imaging Center (CIM) – Uni...
...
A system for in vivo on-demand ultra-low field Overhauser-enhanced 3D-Magnetic resonance imaging
Pubished in the Journal of Magnetic Resonance
...
PrimoGAIA 3rd Steering Committee meeting
The PrimoGAIA 2nd Steering Committee was held in Turin, Italy, on the 13th of September 2022
...
Neutrophil Elastase-Activatable Prodrugs Based on an Alkoxyamine Platform to Deliver Alkyl Radicals Cytotoxic to Tumor Cells
Published in Chemistry Europe
...
